Loading data for ALNY — first visit, this takes a few seconds.
Alnylam Pharmaceuticals, Inc. (ALNY)
NasdaqGS: ALNY
· Real-Time Price · USD
260.10
-6.01 (-2.26%)
At close: Sep 08, 2026, 3:59 PM
The price, the headline numbers and the latest news, in one place.
Alnylam Pharmaceuticals, Inc. (ALNY) Stock Price, Analysis & Data
-2.26% (1D)
| Bid | 243.01 |
| Market Cap | 34.8B |
| Revenue (ttm) | 4.8B |
| Net Income (ttm) | 775M |
| 0.30 | |
| 5.75 | |
| 45.23 | |
| 20.86 | |
| P/B (ttm) | 25.69 |
| P/S (ttm) | 7.24 |
| Earnings Date | Oct 29, 2026 |
| Ask | 235.64 |
| Volume | 1,998,227 |
| Avg. Volume (20D) | 1,813,230 |
| Open | 259.73 |
| Previous Close | 266.11 |
| Day's Range | 254.00 - 272.08 |
| 52-Week Range | 197.81 - 495.55 |
| Analyst | n/a |
| Price Target | n/a |
| Dividends | n/a |
| Ex-Dividend Date | n/a |
About ALNY
Alnylam Pharmaceuticals, Inc. discovers, develops, manufactures, and commercializes therapeutics based on ribonucleic acid interference in the United States, Europe, and internationally. The company offers ONPATTRO for hereditary transthyretin-mediated (hATTR) amyloidosis; AMVUTTRA for ATTR and hATTR amyloidosis; Leqvio for hypercholesterolemia; Qfitlia for hemophilia A or B; GIVLAARI for acute hepatic porphyria; and OXLUMO for primary hyperoxalu...
Industry Biotechnology
Sector Healthcare
IPO Date Jun 1, 2004
Employees 2,500
Stock Exchange NasdaqGS
Ticker Symbol ALNY
Website https://www.alnylam.com
Financial Performance
In 2025, Alnylam Pharmaceuticals's revenue was 3.71B, an increase of 65.19% compared to the previous year's 2.25B. Earnings were 313.75M, a decrease of -212.79%.
Financial StatementsEarnings Surprise
Alnylam Pharmaceuticals has released their quarterly earnings on Jul 30, 2026:
- Revenue of $1.29B misses estimates by $0, with 66.86% YoY growth.
- EPS of 1.84 misses estimates by -0.30, with 475.00% YoY growth.
Alnylam Pharmaceuticals, Inc. is scheduled to release its earnings on Oct 29, 2026, before market opens.
Analysts project revenue of ... Upgrade
Analysts project revenue of ... Upgrade




